SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

ORY (ORY) News

Track canonical SquawkNews coverage tagged to ORY, ORY. This hub brings together deduplicated headlines about nasdaqgs, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol ORY Asset equity Sector Markets 90 days 1 Updated Aug 31, 2026, 06:17 AM UTC Open live news feed
M Oryzon receives U.S. patent allowance for drug combo application Oryzon has received a U.S. patent allowance for its iadademstat and gilteritinib drug combo application. EQUITY | Aug 31, 2026, 06:17 AM UTC